- More than 10.000 experts
- Present in 35+ countries
- More than 60 Laboratories
Local presence, international outlook
In the map below, you will be able to locate all of our active offices worldwide, ranging from the Far East to the United States. We have taken care to include the precise location and contact details of each of our offices, so that you can easily reach out to the one closest to you.
More than just a TIC company
Commitment to Sustainability
More than two-thirds of our services directly relate to Environmental, Social, and/or Governance (ESG) development, underlining our commitment to a sustainable future.
Heritage and Evolution
Established in 1948 with a focus on water safety, Kiwa has evolved into a multifaceted service provider without losing its core value of trust.
Independence and Impartiality
As an independent and impartial entity, Kiwa ensures unbiased and reliable services, free from conflicts of interest.
Introducing Kiwa Lab Capabilities
Navigate through Kiwa's extended landscape of laboratory solutions with our detailed testing directory, embodying the essence of more than 3000 capabilities within 80 laboratories around the globe.
Explore our Laboratory DirectoryExplore the Value of Testing, Inspection, and Certification
-
Project Control Celebrates Milestone at UT Dallas
Project Control, a division of Raba Kistner, Inc. (part of the Kiwa group), celebrates the opening of the Edith and Peter O'Donnell Jr. Athenaeum’s first phase at UT Dallas, featuring world-class art museums. The milestone event also marked the groundbreaking of a cutting-edge performance hall. Discover how this cultural hub is transforming campus life and enriching the arts in North Texas.
-
Quality is more than a certificate; it’s a way of life.
On World Quality Day 2024, Kiwa celebrates the theme ‘Quality: from compliance to performance.’ Quality Manager Eugène den Elzen highlights the importance of embedding quality into company culture, achieving trust and safety, and partnering with experts to enhance performance. Discover how Kiwa supports excellence in quality management and continuous improvement
-
Post-Market Surveillance: Key Considerations for Medical Device Compliance
Post-market surveillance (PMS) has undergone significant transformation under the Medical Device Regulation (MDR) in Europe. It marks a new era in the monitoring and reporting of medical device safety and performance. This set of requirements emphasizes the proactive collection and analysis of medical device-related data after a product is placed on the market, allowing manufacturers to reassess the safety and effectiveness of their medical devices continuously.